Is Repligen (RGEN) The Best Healthcare Stock to Buy Now? [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
Dan Veru, Palisade Capital Management senior partner and CIO, recently talked about Repligen, a life sciences company involved in the development and production of materials used in the manufacture of biological drugs. Here is why the analyst likes the stock, which is up 10% over the past 12 months. “You need a clearance event. You need something to happen to remove the uncertainties, and I think what's happened in the last couple of days vis-à-vis drug pricing really was that clearance event. Repligen Corp (NASDAQ:RGEN) is no different than Danaher in many respects, which you and I have talked about as well. They are part of the whole ecosystem of how you make drugs and a very important component of that. The stock's been plagued by simply uncertainty over the direction of drug pricing. Now, at least you have better clarity, and it's more and more important as we get more that we're going to need more drugs to come out, and they would play in that ecosystem of how new drugs are fo
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- Repligen (NASDAQ:RGEN) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Repligen Corporation to Present at Evercore Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Repligen Corporation to Present at Evercore Healthcare ConferenceGlobeNewswire
- Why Repligen (RGEN) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Repligen (NASDAQ:RGEN) had its "sell (d+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
RGEN
Earnings
- 10/28/25 - Beat
RGEN
Sec Filings
- 11/26/25 - Form 4
- 11/25/25 - Form 144
- 11/19/25 - Form 4
- RGEN's page on the SEC website